OLUSOLA OLAWALE: Open Payments
NPI 1205327764 · HAMPTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 10 payments from 4 companies in 2025. Trend: 2023 $154 · 2024 $88 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lundbeck LLC | 1 | $27 |
Products named: INGREZZA, ABILIFY MAINTENA, CAPLYTA, REXULTI, ABILIFY ASIMTUFII.
Industry payments across GA — which companies pay providers there.
